Pathkey.AI Ltd (ASX:PKY)

Australia flag Australia · Delayed Price · Currency is AUD
0.0520
+0.0110 (26.83%)
Apr 29, 2026, 4:11 PM AEST
100.00%
Market Cap 24.89M
Revenue (ttm) 290.26K
Net Income (ttm) -1.44M
Shares Out 607.08M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 73,162,456
Average Volume 1,572,635
Open 0.0680
Previous Close 0.0410
Day's Range 0.0500 - 0.0710
52-Week Range 0.0140 - 0.0630
Beta 1.06
RSI 81.78
Earnings Date May 27, 2026

About Pathkey.AI

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathke... [Read more]

Sector Healthcare
Founded 1994
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol PKY
Full Company Profile

Financial Performance

In fiscal year 2025, Pathkey.AI's revenue was 321,991, a decrease of -65.45% compared to the previous year's 932,076. Losses were -1.45 million, -53.75% less than in 2024.

Financial Statements

News

There is no news available yet.